Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced Tuesday that it received a deficiency letter from the Nasdaq Listing Qualifications Department, notifying the company that its common stock ...

Tharimmune, Inc. (NASDAQ: THAR) (“Tharimmune” or the “Company”), the first publicly traded company to leverage Canton Coin (“CC”) to support the Canton Network’s ability to digitize traditional ...

HONG KONG SAR, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Mint Incorporation Limited (Nasdaq: MIMI) ("Mint" or the "Company"), a leading Hong Kong-based technology company and interior design and fit out works ...

Milestone Underscores Accelerating Institutional Adoption of Blockchain Technology and Aligns with Tharimmune's Canton Coin Treasury Strategy NEW YORK, Dec. 18, 2025 /PRNewswire/ -- Tharimmune, Inc.

Under the oversight of the Board on Army Research and Development (BOARD), a committee to be named the Research Program Review and Analysis Committee (RPAC) will review a subset of the Army's research ...

Relative Energy Deficiency in Sport (REDs) was first introduced in 2014 by the International Olympic Committee’s expert writing panel, identifying a syndrome of deleterious health and performance ...

Ashlyn is one of Forbes Home's in-house writers and a former civil engineer-turned content writer with over six years experience. Until recently, Ashlyn focused on creating content for Forbes Home as ...

NEW YORK, Dec. 18, 2025 /PRNewswire/ -- Tharimmune, Inc. (THAR), the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize traditional financial ...

Pathward Financial, Inc. (“Pathward Financial” or the “Company”) (Nasdaq: CASH) received an expected notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC ...

Ukko Inc. has announced plans to initiate clinical trials with UKK-0018 for peanut allergy in the first half of this year.